Navigation Links
Mayo Clinic: Scheduled imaging studies provide little help detecting relapse of aggressive lymphoma
Date:5/16/2013

ROCHESTER, Minn. -- Imaging scans following treatment for diffuse large B-cell lymphoma do little to help detect a relapse, a Mayo Clinic study has found. The overwhelming majority of patients with this aggressive lymphoma already have symptoms, an abnormal physical exam or an abnormal blood test at the time of relapse, the researchers say. The findings will be presented at the American Society of Clinical Oncology annual meeting May 31-June 4 in Chicago.

"Our results were surprising because the current standard-of-care is to include scans for the follow-up of this disease," says lead author Carrie Thompson, M.D., a Mayo Clinic hematologist. "We found that scans detected relapse in only a handful of patients who didn't have any of those other signs or symptoms. I think our study suggests that we are getting closer to understanding how to optimize follow-up in this patient population."

Diffuse large B-cell lymphoma is the most common type of non-Hodgkin lymphoma, with nearly 20,000 new cases diagnosed in the United States each year. The aggressive lymphoma can be cured if treated in its early stages. The cancer will come back in 20 to 30 percent of cases, and the best strategy for catching that relapse is unclear. In this study, Dr. Thompson and her colleagues looked at patients in remission to identify how relapses were detected.

Researchers followed 537 patients treated with anthracycline-based immunochemotherapy and enrolled in the Mayo Clinic/University of Iowa Special Program of Research Excellence (SPORE) Molecular Epidemiology Resource. Of the 109 patients who relapsed, 62 percent went to the doctor earlier than a planned follow-up visit due to the re-emergence of symptoms such as enlarged lymph nodes, fever, night sweats, pain or weight loss. At the time of relapse, 68 percent had symptoms, 42 percent had an abnormal physical exam, and 55 percent had an abnormal blood test. Performing surveillance scans detected relapse in only eight patients whose symptoms had not yet started to reappear.

Dr. Thompson is now interested in surveying physicians and patients to assess their attitudes and beliefs surrounding the use of scans during remission. Her previous work suggested that patients experience a significant amount of anxiety waiting for a follow-up scan.

"Sometimes scans can provide reassurance, but, at the same time, the anticipation of a scan can provoke quite a bit of anxiety," Dr. Thompson says. "And we know from this data that scans detected relapses only in a minority of patients. So we need to think about how we can individualize care to particular patients, keeping in mind their disease, their experience and their fears. Further studies are necessary to determine the optimal follow-up strategy."


'/>"/>

Contact: Joe Dangor
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Related medicine news :

1. Mayo Clinic: New multiple myeloma treatment guidelines personalize therapy for patients
2. Mayo Clinic: Skin problems, joint disorders top list of reasons people visit doctors
3. Mayo Clinic: 2-drug combination may slow deadly thyroid cancer
4. Mayo Clinic: Less invasive surgery detects residual breast cancer in lymph nodes after chemotherapy
5. Mayo Clinic: Antidepressant eases radiation-related mouth pain in head, neck cancer
6. Mayo Clinic: Diabetes can be controlled in patients after pancreas removal
7. Mayo Clinic: Drug duo turns on cancer-fighting gene in kidney, breast cancers
8. Mayo Clinic: Common blood pressure drug linked to severe GI problems
9. Mayo Clinic: Molecule thought cancer foe actually helps thyroid tumors grow
10. Mayo Clinic: Standard heart disease risk tools underrate danger in rheumatoid arthritis
11. Mayo Clinic: Exhaustion renders immune cells less effective in cancer treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2017)... (PRWEB) , ... September 21, 2017 , ... ... with offices serving communities in northern Alabama and Georgia, is embarking on an ... prevention by utilizing modern early detection methods. , US Breast Cancer statistics ...
(Date:9/20/2017)... ... September 20, 2017 , ... Collins Concrete Coatings announced that ... rely on safety and cleanliness. This unique flooring system uses silver ion technology ... for centuries for its antimicrobial properties. Unlike antibiotics, which kill specific microorganisms, silver ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... company specializing in medical device compliance and commercialization, has just released a ... activities. , FDA is more adamant than ever about medical device, pharmaceutical, ...
(Date:9/20/2017)... Cleveland, Ohio (PRWEB) , ... September 20, 2017 ... ... commitment to customer service and innovation, the company recently unveiled a redesigned website. ... to further enrich the work of building owners, architects, contractors and other industry ...
(Date:9/20/2017)... ... September 20, 2017 , ... The Honey Pot Company is ... goal is to ignite conversation via social media and word-of-mouth regarding vaginal health, ... declared September “Humans with Vaginas” month, releasing a video celebrating the power of ...
Breaking Medicine News(10 mins):
(Date:9/5/2017)... -- Just 18 months after its February 2016 launch, market ... appointment of three new senior people to its rapidly ... and James Wright bring decades of ... Tammy Wynne joins as Director, Value ... has over ten years, experience in global market access ...
(Date:8/31/2017)... PM360,s annual Innovations Issue, published in ... innovations happening across the industry. Established six years ago, ... providing a comprehensive look at the newest and most ... innovative companies, startups, divisions, products, services, and strategies from ... "Everyone in this industry wants to do better—in all ...
(Date:8/25/2017)... -- Innovation Zed ( www.innovationzed.com ), an Irish medtech company, today announced that ... and Bassetlaw, England . The ... as part of a national NHS Test Bed programme exploring new models ... Innovation Zed ... InsulCheck Connect, a snap-on accessory for disposable insulin pen users, automatically collects ...
Breaking Medicine Technology: